Third Arc Bio’s $165 Million Series A Financing Round

Wilson Sonsini Goodrich & Rosati advised Vida Ventures on IP matters related to the transaction.Third Arc Bio Inc., a biotech company, announced a $165 million oversubscribed…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Leila Ahmed

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here